PDF) Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis
Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease | American Academy of Pediatrics
Kawasaki disease
Kawasaki Disease | Obgyn Key
Evaluation of suspected incomplete Kawasaki disease. (1) In the absence... | Download Scientific Diagram
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría (English Edition)
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease
Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar
Kawasaki disease: AHA statement and recommendations | Contemporary Pediatrics
Kawasaki disease: AHA statement and recommendations | Contemporary Pediatrics
Kawasaki Disease – The Leading Cause of Acquired Heart Disease In Children In The USA | Tom Wade MD
Kawasaki Disease
2017 AHA Guidelines On Kawasaki Disease – A Link And Excerpts | Tom Wade MD
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Kawasaki disease: AHA statement and recommendations | Contemporary Pediatrics
Clinical Practice Guidelines : Kawasaki disease
Disease of the Week: Kawasaki Disease - UCSD Guardian
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
Kawasaki disease - diagnosis and treatment
Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease | American Academy of Pediatrics
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health
Full text] Refractory Kawasaki disease: diagnostic and management challenges | PHMT